Others

Aurobindo Pharma Ltd. - Analyst / Investor Call

| Updated on February 05, 2019 Published on February 05, 2019

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that an analyst / investor call on the Unaudited Financial Results of the Company for the third quarter and nine months period ended 31st December 2018 is scheduled on 8th February 2019 at 8:30 AM. Please find attached the dial-in details of the call.

Pdf Link: Aurobindo Pharma Ltd. - Analyst / Investor Call

Source : BSE - www.bseindia.com

Published on February 05, 2019
This article is closed for comments.
Please Email the Editor